• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number E324-KIT
Device Problem Device Displays Incorrect Message (2591)
Patient Problems Low Blood Pressure/ Hypotension (1914); Unspecified Infection (1930); Tachycardia (2095)
Event Date 07/26/2016
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.A batch record review of kit lot e324 was conducted.There were no nonconformances associated with this lot.The lot met release requirements.Uvadex lot# ae0046 (manufacture date: 04/07/2015 and expiration date 03/31/2018) was reviewed.No trends or nonconformances related to the complaint were noted.Trends were reviewed for complaint categories, alarm #45: red blood cell pump alarm, hypotension, heart rate increase, and central line infection.No trends were detected for these complaint categories.From a device perspective, there is no known device malfunction.However, since the physicians were not able to rule out ecp as a possible cause for the central line infection and the device may have contributed to the spread of the infection, this case is being reported out of an abundance of caution.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: hypotension, tachycardia, and infection.(b)(4).Device not returned to manufacturer.
 
Event Description
On (b)(6) 2016, the customer reported that an alarm #45: red blood cell pump alarm occurred after approximately 360 ml of whole blood processed.The customer stated that they were able to force the buffy coat at this point.The customer reported that the patient had been intubated prior to the extracorporeal photopheresis (ecp) procedure, but the reason for this incubation was not stated.The customer stated that the patient experienced both hypotension and tachycardia during reinfusion, which was at a rate of 5 ml/minute.The customer supplied flow sheet of the patient's ecp treatment showed that the patient started out with a low blood pressure and the medical professionals were fine with the mean arterial pressure (map) staying at or greater than 50.The flow sheet indicated that the patient's tachycardic event occurred when the patient's heart rate spiked into the 180s during the blood return.There was no medical intervention reported for the patient, although the patient's flow sheet did state that the medical team was present at the patient's bedside.The tachycardia appeared to have spontaneously resolved on its own, according to the patient's ecp flow sheet.The customer stated that the treatment was completed with a treatment volume of 127 ml ,and the patient's ending fluid balance was +154 ml.The customer also reported that the patient had an infected/septic line due to aseptic techniques, however it was unclear if the infection occurred prior to or during the ecp treatment.The customer stated that the hospital discovered that the patient's line was septic after a (b)(6) 2016 culture came back positive.The customer stated that the patient was started on antibiotics later that day.The customer reported that it is unknown when the line became septic or who exactly had been accessing the line (the patient was in picu).The customer stated that the central line had been placed approximately one week prior to the ecp treatment.The kit was not returned for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS, INC
hampton NJ
Manufacturer (Section G)
THERAKOS, INC.
10 north high street
suite 300
west chester PA 19380
Manufacturer Contact
megan vernak
53 frontage road
hampton, NJ 08827
MDR Report Key5918753
MDR Text Key53664431
Report Number2523595-2016-00193
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Nurse
Type of Report Initial
Report Date 08/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Nurse
Device Expiration Date05/01/2018
Device Lot NumberE324-KIT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/02/2016
Initial Date FDA Received08/31/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Weight11
-
-